Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
228,500
+70,000
+44% +$132K 0.09% 83
2026
Q1
$142K Hold
158,500
0.04% 83
2025
Q4
$160K Buy
+158,500
New +$197K 0.04% 92

Other funds holding IFRX

DCF Advisers's IFRX Position: Q2 2026 in Review

DCF Advisers increased its InflaRx (IFRX) stake by 44% in Q2 2026, buying an estimated $132K and bringing the position to 228,500 shares worth $512K. The position accounts for 0.09% of the portfolio, ranked #83.

DCF Advisers first reported a position in IFRX in Q4 2025 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • DCF Advisers held 228,500 shares of InflaRx worth $512K as of Q2 2026.
  • DCF Advisers bought 70,000 InflaRx shares in Q2 2026, an estimated $132K.
  • InflaRx made up 0.09% of DCF Advisers's portfolio in Q2 2026, its #83 holding.
  • DCF Advisers first reported a position in InflaRx in Q4 2025 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.